Vaxcyte, Inc 10-Q for FY2023 Q3
Vaxcyte, Inc. (PCVX)
10-Q
2023-11-06
For: 2023-09-30
View Original
Added on
April 07, 2026
About this 10-Q
Vaxcyte, Inc filed this 10-Q on November 6, 2023, covering the quarter ended September 30, 2023 (FY2023 Q3).
Headline figures
Quarter ended September 30, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Net loss
- $92.66M
- compared with a net loss of $57.92M a year earlier
- Diluted EPS
- -$0.91
- compared with -$0.93 a year earlier